WisdomTree Trust. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| TWIST BIOSCIENCE CORPTWST | 5.95% | $159.26K | 1,548 |
| MODERNA INCMRNA | 4.14% | $110.93K | 1,584 |
| ELI LILLY & COMPANYLLY | 4.08% | $109.15K | 91 |
| JOHNSON & JOHNSONJNJ | 2.97% | $79.49K | 313 |
| UNITED THERAPEUTICS CORPUTHR | 2.45% | $65.56K | 121 |
| NATERA INCNTRA | 2.32% | $62.16K | 229 |
| TEMPUS AI INCTEM | 2.28% | $61.12K | 1,055 |
| IMMUNOME INCIMNM | 2.26% | $60.39K | 2,850 |
| STRUCTURE THERAPEUTICS INCGPCR | 2.11% | $56.62K | 1,055 |
| STOKE THERAPEUTICS INCSTOK | 2.09% | $56.02K | 1,712 |
| BEAM THERAPEUTICS INCBEAM | 2.09% | $55.87K | 1,628 |
| CORTEVA INCCTVA | 1.99% | $53.27K | 629 |
| KRYSTAL BIOTECH INCKRYS | 1.96% | $52.41K | 141 |
| DARLING INGREDIENTS INCDAR | 1.94% | $51.83K | 949 |
| IONIS PHARMACEUTICALS INCIONS | 1.86% | $49.71K | 627 |
| ASTRAZENECA PLC | 1.83% | $48.92K | 258 |
| 10X GENOMICS INCTXG | 1.81% | $48.46K | 1,264 |
| CRISPR THERAPEUTICS AG | 1.77% | $47.34K | 868 |
| BAYER AG | 1.53% | $46.89K | 741 |
| ROIVANT SCIENCES LTD | 1.73% | $46.36K | 1,310 |
| ABSCI CORPABSI | 1.71% | $45.65K | 3,939 |
| REVOLUTION MEDICINES INCRVMD | 1.69% | $45.13K | 241 |
| NOVARTIS AG | 1.33% | $44.16K | 227 |
| AGIOS PHARMACEUTICALS INCAGIO | 1.57% | $42.08K | 1,134 |
| AMGEN INCAMGN | 1.54% | $41.28K | 114 |
| THERMO FISHER SCIENTIFIC INCTMO | 1.52% | $40.61K | 81 |
| GILEAD SCIENCES INCGILD | 1.51% | $40.43K | 320 |
| BUNGE GLOBAL SA | 1.51% | $40.34K | 378 |
| ARROWHEAD PHARMACEUTICALS INCARWR | 1.47% | $39.45K | 484 |
| VERACYTE INCVCYT | 1.46% | $39.11K | 666 |
| BIOHAVEN LTD | 1.37% | $36.80K | 2,473 |
| PFIZER INCPFE | 1.34% | $35.98K | 1,494 |
| VERTEX PHARMACEUTICALS INCVRTX | 1.34% | $35.76K | 72 |
| UNIQURE NV | 1.23% | $32.84K | 713 |
| CATALYST PHARMACEUTICALS INC | 1.07% | $28.73K | 914 |
| EXELIXIS INCEXEL | 1.04% | $27.97K | 514 |
| CULLINAN THERAPEUTICS INCCGEM | 1.04% | $27.90K | 1,532 |
| PROTAGONIST THERAPEUTICS INCPTGX | 1.03% | $27.46K | 224 |
| DYNE THERAPEUTICS INCDYN | 1.00% | $26.76K | 1,205 |
| CELLDEX THERAPEUTICS INCCLDX | 0.96% | $25.82K | 694 |
| EDITAS MEDICINE INCEDIT | 0.95% | $25.53K | 7,881 |
| ARGENX SEARGX | 0.94% | $25.05K | 27 |
| VIKING THERAPEUTICS INCVKTX | 0.93% | $24.93K | 639 |
| REGENXBIO INCRGNX | 0.93% | $24.91K | 2,079 |
| CG ONCOLOGY INCCGON | 0.90% | $24.16K | 340 |
| BIONTECH SEBNTX | 0.88% | $23.45K | 252 |
| BIOGEN INCBIIB | 0.82% | $22.04K | 102 |
| ALLOGENE THERAPEUTICS INCALLO | 0.82% | $21.90K | 10,528 |
| IOVANCE BIOTHERAPEUTICS INCIOVA | 0.77% | $20.56K | 4,942 |
| VERBIO VEREINIGTE BIOENERGIE SE | 0.66% | $20.26K | 520 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.